Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: Interim findings

Health Technology Assessment

Volumn 14, Issue 46, 2010, Pages 237-354

  Killingley, B ^a   Greatorex, J ^b   Cauchemez, S ^c   Enstone, J E ^a   Curran, M ^b   Read, R C ^d   Lim, W S ^e   Hayward, A ^f   Nicholson, K G ^g   Nguyen Van Tam, J S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AEROSOL; ARTICLE; CHILD; CONFIDENCE INTERVAL; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOMITE; HEALTH; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; INFORMATION PROCESSING; MALE; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS; TIME; VIRUS LOAD; VIRUS SHEDDING;

ADOLESCENT; ADULT; AEROSOLS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DATA COLLECTION; DISEASE OUTBREAKS; ENVIRONMENTAL MICROBIOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOMITES; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS AS TOPIC; TIME FACTORS; VIRAL LOAD; VIRUS SHEDDING; WORLD HEALTH; YOUNG ADULT;

EID: 79952202149     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta14460-04     Document Type: Article

References (56)

1. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006;12:1657-1662.
2. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis 2007;7:257-265.
3. Department of Health. Pandemic (H1N1) 2009 Influenza: a summary of guidance for infection control in healthcare settings. 2009. URL: www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_110899.pdf.
4. Boivin G, Goyette N, Hardy I, Aoki F, Wagner A, Trottier S. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults. J Infect Dis 2000;181:1471-1474.
5. Lau LL, Cowling BJ, Fang VJ, Chan KH, Lau EH, Lipsitch M, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010;201:1509-1516.
6. Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DK, Cheng CK, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 2010;50:707-714.
7. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-1024.
8. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981;144:433-441.
9. Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009;200:492-500.
10. Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, Sampathkumar P. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007;28:1071-1076.
11. Sato M, Hosoya M, Kato K, Suzuki H. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J 2005;24:931-932.
12. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507-2517.
13. Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010. 50: pp. 963-969.
14. Suess T, Buchholz U, Dupke S, Grunow R, Matthias Ander H, Heider A, et al. Shedding and transmission of novel influenza virus A H1N1 infection in households: Germany 2009. Am J Epidemiol 2010;71:1157-1164.
15. To KK, Chan KH, Li IW, Tsang TY, Tse H, Chan JF, et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 2010;82:1-7.
16. van Doorn RH. Influenza pandemic (H1N1) 2009 (68): Viet Nam, virus clearance. 2009. URL: www.promedmail.org/pls/apex/f?p=2400:1001:1739427750156980::NO::F2400_P1001_BACK_PAGE,F2400_P1001_PUB_MAIL_ID:1004,79587.
17. Reed SE. An investigation of the possible transmission of Rhinovirus colds through indirect contact. J Hyg 1975;75: 249-258.
18. Hall CB, Douglas RG, Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981;99:100-103.
19. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH, Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;146:47-51.
20. Thomas Y, Vogel G, Wunderli W, Suter P, Witschi M, Koch D, et al. Survival of influenza virus on banknotes. Appl Environ Microbiol 2008;74:3002-3007.
21. Boone SA, Gerba CP. The occurrence of influenza A virus on household and day care center fomites. J Infect 2005;51:103-109.
22. Pappas DE, Hendley JO, Schwartz RH. Respiratory viral RNA on toys in pediatric office waiting rooms. Pediatr Infect Dis J 2010;29:102-104.
23. Loosli CG, Lemon HM, Robertson OH, Appel E. Experimental airborne influenza infection.I. Influence of humidity on survival of virus in air. Proc Soc Exp Biol Med 1943;53:205-206.
24. Wells WF, Brown HW. Recovery of influenza virus suspended in air. Science 1936;84:68-69.
25. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966;122:800-804.
26. Blachere FM, Lindsley WG, Pearce TA, Anderson SE, Fisher M, Khakoo R, et al. Measurement of airborne influenza in a hospital emergency department. Clin Infect Dis 2009;48:438-440.
27. Lindsley WG, Blachere FM, Davis KA, Pearce TA, Fisher MA, Khakoo R, et al. Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis 2010;50:693-698.
28. McLean RL. The effect of ultraviolet radiation upon the transmission of epidemic influenza in long term hospitals. Am Rev Respir Dis 1961;83:36-38.
29. Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter DG. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 1979;110:1-6.
30. Han K, Zhu X, He F, Liu L, Zhang L, Ma H, et al. Lack of airborne transmission during outbreak of pandemic (H1N1) 2009 among tour group members: China, June 2009. Emerg Infect Dis 2009;15:1578-1581.
31. Nicas M, Nazaroff WW, Hubbard A. Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005;2:143-154.
32. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic Influenza. Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection. N Engl J Med 2010;362:1708-1719.
33. De Serres G, Rouleau I, Hamelin ME, Quach C, Skowronski D, Flamand L, et al. Contagious period for pandemic (H1N1) 2009. Emerg Infect Dis 2010;16:783-788.
34. Li IW, Hung IF, To KK, Chan KH, Wong SS, Chan JF, et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010;137:759-768.
35. Schutten M, Lina CBB, Monto A, Osterhaus A, Nguyen Van-Tam J, Whitley RJ. Neuraminidase inhibitor (NAI) treatment in a 2009-H1N1 influenza A-infected patient population: The IRIS Study. Options for the control of influenza VII. 2010, Hong Kong, poster 167.
36. Tiwari A, Patnayak DP, Chander Y, Parsad M, Goyal SM. Survival of two avian respiratory viruses on porous and nonporous surfaces. Avian Dis 2006;50:284-287.
37. Hinds WC. Aerosol technology. 2nd edn. New York, NY: John Wiley and Sons; 1999.
38. Fabian P, McDevitt JJ, Houseman EA, Milton DK. Airborne influenza virus detection with four aerosol samplers using molecular and infectivity assays: considerations for a new infectious virus aerosol sampler. Indoor Air 2000;19:433-441.
39. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009;6:S783-S790.
40. Mubareka S, Lowen AC, Steel J, Coates AL, Garcia-Sastre A, Palese P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 2009;199:858-865.
41. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009;325:481-483.
42. Nicas M, Sun G. An integrated model of infection risk in a health-care environment. Risk Anal 2006; 26:1085-1096.
43. Couch RB, Cate TR, Douglas RG, Jr, Gerone PJ, Knight V. Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol Rev 1966;30:517-529.
44. Douglas R. Influenza in man. In Kilbourne ED, editor. The influenza viruses and influenza. New York, NY: Academic Press; 1975.
45. Nicas M and Jones RM. Relative contributions of four exposure pathways to influenza infection risk. Risk Anal 2009;29:1292-1303.
46. Colthart DG. Pandemic influenza and swine flu. 2009. URL: www.parliament.uk/briefingpapers/commons/lib/research/briefings/snsc-05059.pdf
47. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010;375: 1100-1108.
48. Chan M, Chen MI, Chow A, Lee CP, Tan AS, Lye DC, et al. Pandemic (H1N1) 2009: clinical and laboratory findings of the first fifty cases in Singapore. Ann Acad Med Singapore 2010;39:267-272.
49. Nguyen-Van-Tam J, Openshaw P, Hasim A, Gadd E, WS L, Semple M, et al. Risk factors for hospitalisation and poor outcome with pandemic A/ H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010;65:645-651.
50. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus: United States 2009. MMWR Morb Mortal Wkly Rep 2009;58:826-829.
51. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009;45:191-195.
52. Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis 2009;49:1090-1093.
53. Ngaosuwankul N, Noisumdaeng P, Komolsiri P, Pooruk P, Chokephaibulkit K, Chotpitayasunondh T, et al. Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses. Virol J 2010;7:75.
54. Spyridaki IS, Christodoulou I, de Beer L, Hovland V, Kurowski M, Olszewska-Ziaber A, et al. Comparison of four nasal sampling methods for the detection of viral pathogens by RT-PCR-A GA(2) LEN project. J Virol Methods 2009;156:102-106.
55. Sung RY, Chan PK, Choi KC, Yeung AC, Li AM, Tang JW, et al. Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection. J Clin Microbiol 2008;46:3073-3076.
56. Heikkinen T, Salmi AA, Ruuskanen O. Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza. BMJ 2001;322:138.